AC
SANA icon

AXQ Capital’s Sana Biotechnology SANA Stock Holding History

AXQ Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Sell
37,771
-19,140
-34% -$61.7K 0.01% 777
2026
Q1 		$164K Buy
56,911
+1,508
+3% +$5.94K 0.02% 794
2025
Q4 		$225K Buy
55,403
+37,177
+204% +$166K 0.05% 533
2025
Q3 		$64.7K Sell
18,226
-38,774
-68% -$140K 0.02% 538
2025
Q2 		$156K Buy
+57,000
New +$118K 0.05% 485

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

AXQ Capital's SANA Position: Q2 2026 in Review

AXQ Capital reduced its Sana Biotechnology (SANA) stake by 34% in Q2 2026, selling an estimated $61.7K and leaving 37,771 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #777.

AXQ Capital first reported a position in SANA in Q2 2025 and has held it in 5 quarters since. The position peaked at $225K in Q4 2025. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • AXQ Capital held 37,771 shares of Sana Biotechnology worth $132K as of Q2 2026.
  • AXQ Capital sold 19,140 Sana Biotechnology shares in Q2 2026, an estimated $61.7K.
  • Sana Biotechnology made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #777 holding.
  • AXQ Capital first reported a position in Sana Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • AXQ Capital's Sana Biotechnology position peaked at $225K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.